Skip To Main Content
Hùng Lê on Muck Rack

Hùng Lê

As seen in: Forbes, Nature, ABC News (Australia), arXiv, MDPI, Sydney Morning Herald, JAMA Network, The Age, Royal Society of Chemistry, VnExpress.net and

Get in touch with Hùng

Contact Hùng, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Hùng Lê’s Journalist Portfolio

Dai ly Noi That Hoa Phat tai Mien Trung - Hoa Phat Group

Dai ly Noi That Hoa Phat tai Mien Trung - Hoa Phat Group

He thong dai ly Noi That Hoa Phat rong nhat Viet Nam - Chung toi mang lai cho Ban trai nghiem ve san pham Noi…

View article →

Articles

Outcomes of early-onset vs average-onset colorectal cancer patients on phase I matched and non-matched therapies

|
By Daniel Fox, Deepak Bhamidipati, Heather Y. Lin, Louis E. Hinkle, Caitlynn Pham, Stéphane Champiat, Ecaterina E. Dumbrava, Siqing Fu, Lei Kang, Hung Le, Hùng Lê, Funda Meric-Bernstam, Aung Naing, Sarina Piha-Paul, Paula R Pohlmann, Tin-Yun Tang, Apostolia M. Tsimberidou, Timothy A. Yap, Ryan W. Huey, David Hong, Jordi R. Ahnert
| Nature Verified
Abstract Early-onset colorectal cancer (EOCRC) is an increasingly prevalent disease with no age-specific therapies despite evidence suggesting biologic differences between EOCRC and average-onset CRC (AOCRC).
Open in Who Shared Issue with article?

Obstacles to business growth and how to overcome them

|
By Hung Le, Hùng Lê
| Sage - ES
Business growth can be exciting, but it rarely comes without pressure. As your company expands, new opportunities can open up for your customers, your workforce, and the business as a whole. But growth can also expose weaknesses in your processes, finances, systems, and management structure. The work ethic that helped you get started may not be enough to support the next stage. That’s why it’s important to anticipate the business challenges that can arise as your project grows.
Open in Who Shared Issue with article?

Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck Cancer

|
By Harold Nathan Tan, Bettzy Stephen, Oriol Mirallas, Mohamed H. Derbala, Israa Fouad Salih, Hung Le, Hùng Lê, Heather Y. Lin, Joann G. Lim, Ecaterina E. Dumbrava, Timothy A. Yap, Jordi Rodon, Sarina Piha-Paul, Siqing Fu, Stéphane Champiat, Neal S. Akhave, Renata Ferrarotto, David Hong, Funda Meric-Bernstam, Faye M. Johnson, Aung Naing, Lilibeth Castillo
| JAMA Network Verified
Supplement 1. eMethods 1. Translational Correlates eMethods 2. Model Assumption Testing eTable 1. Viral Status and Molecular Findings eTable 2. Investigational Immuno-Oncology Treatment Profile eTable 3. Best Overall Responses in the Study Cohort eTable 4. Factors Associated With Clinical Benefit Rate eTable 5. Factors Associated With PFS eTable 6. Factors Associated With OS eFigure 1. Study Cohort Flow Diagram eFigure 2. PD-L1 Expression by Anatomic Site eFigure 3.
Open in Who Shared Issue with article?
See all 490 licensed articles (498 Total)